Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Akebia Therapeutics, Inc. - Common Stock
(NQ:
AKBA
)
0.7145
-0.0555 (-7.21%)
Delayed Quote
Updated: 3:29 PM EDT, Oct 14, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Akebia Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Akebia Therapeutics (NASDAQ:AKBA) Slides 24.6% Despite Q2 Earnings Beat
↗
August 05, 2026
Via
Chartmill
Akebia Therapeutics Q2 Earnings Call Highlights
↗
August 05, 2026
Akebia Therapeutics (NASDAQ:AKBA) reported second-quarter revenue growth for its Vafseo anemia treatment while highlighting an interim clinical result from the VOICE study and progress across its...
Via
MarketBeat
Topics
Earnings
Akebia Therapeutics Sees Vafseo Uptake Rising as Access and Pipeline Milestones Near
↗
June 04, 2026
Akebia Therapeutics (NASDAQ:AKBA) outlined its commercial priorities for Vafseo, the expected evolution of reimbursement after the TDAPA period and several renal-disease pipeline programs during a...
Via
MarketBeat
Topics
Intellectual Property
Akebia (AKBA) Q1 2026 Earnings Transcript
↗
May 08, 2026
Akebia (AKBA) Q1 2026 Earnings Transcript
Via
The Motley Fool
Akebia Therapeutics Inc (NASDAQ:AKBA) Reports Q4 Revenue Beat and 49% Annual Growth Amid Mixed Market Reaction
↗
February 26, 2026
Via
Chartmill
Earnings Scheduled For November 10, 2025
↗
November 10, 2025
Via
Benzinga
An Overview of Akebia Therapeutics's Earnings
↗
November 07, 2025
Via
Benzinga
Akebia (AKBA) Q4 2025 Earnings Call Transcript
↗
February 26, 2026
Akebia (AKBA) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
AKBA Shares Rise On Clinical Pipeline Optimism As Anemia Drug Gains Traction
↗
February 26, 2026
The company said on Thursday that it now expects its mid-stage trial of AKB-097 in rare kidney diseases to start in the second half of 2026, with initial data expected in 2027.
Via
Stocktwits
Q32 Bio Stock Soars On Selling Experimental Drug To Akeba For Up To $592M
↗
December 01, 2025
The company said that the sale extends its cash runway into the second half of 2027.
Via
Stocktwits
12 Health Care Stocks Moving In Monday's Intraday Session
↗
November 10, 2025
Via
Benzinga
Akebia Therapeutics Stock Slumps After FDA Meeting Ends Without Path Forward for Vafseo Label Expansion
↗
October 29, 2025
Via
Stocktwits
Earnings Scheduled For August 7, 2025
↗
August 07, 2025
Via
Benzinga
Earnings Preview For Akebia Therapeutics
↗
August 06, 2025
Via
Benzinga
Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November
↗
November 04, 2025
Via
Benzinga
FDA Pushback Prompts Akebia To Drop Broad Label Pursuit For Kidney Disease Drug
↗
October 29, 2025
Akebia shares decline after the company ends plans for its VALOR trial, citing FDA feedback and high costs tied to expanding Vafseo's label.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
October 29, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 29, 2025
Via
Benzinga
Earnings Scheduled For May 8, 2025
↗
May 08, 2025
Via
Benzinga
Insights Ahead: Akebia Therapeutics's Quarterly Earnings
↗
May 07, 2025
Via
Benzinga
Mondelez International, Stride, Varonis Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
↗
October 29, 2025
Via
Benzinga
Why Teradyne Shares Are Trading Higher By More Than 20%; Here Are 20 Stocks Moving Premarket
↗
October 29, 2025
Via
Benzinga
Wondering what's happening in today's after-hours session?
↗
October 28, 2025
As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
October 28, 2025
Via
Benzinga
Akebia (AKBA) Q2 Revenue Jumps 43%
↗
August 07, 2025
Via
The Motley Fool
9 Health Care Stocks Whale Activity In Today's Session
↗
June 04, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
May 08, 2025
Via
Benzinga
Here are the top movers in Thursday's session.
↗
March 20, 2025
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.
Via
Chartmill
Top movers in Thursday's session
↗
March 20, 2025
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
March 20, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
